Website is intended for physicians



Recent decades exhibit a tendency to the rise of gynecological malignant tumors occurence, which makes a substantial contribution to women mortality rate. Wide application of surgery makes it crucial to specify the nature of a lesion, its location, and the degree of the neighboring tissue and lymphatic nodes involvement. Early recognition, accurate staging and localization, and timely recurrent tumor detection are the primary tasks of radiodiagnostics. Computed tomography and magnetic resonance imaging show good results in gynecological tumors detection.

Clinical application of new radiological methods develops the diagnostic accuracy, decreases the number of errors and improves the survival rate. The basic radiological diagnostic procedures and the possibilities of their clinical application are discussed in the article in a form of the survey of literature.



1.     Альбицкий В.Ю. и др. Репродуктивное здоровье и поведение женщин в России. Казань: Медицина. 2001; 25-27.

2.     Parker S.L. et al. Cancer statistics. Cancer. J. Clin.1996; 65: 5-27.

3.     Берека Дж. и др. Гинекология по Эмилю Новаку. Пер. с англ. М. 2002; 731-770.

4.     Карселадзе А.И. Морфология эпителиальныхяичников. Дис. д-ра мед. наук. М. 1989; 10-12.

5.     Хендлер Ф. Карцинома яичников. Пер. с англ.М. 2004; 1045-1067.

6.     Онкологическая гинекология. Тексты клинических лекций. М.: Изд-во Университетадружбы народов. 1985; 256.

7.     БолдогоеваИ.М. Совершенствование инструментальных методов в диагностике ракаяичников. Дис. кан. мед. наук. Уфа. 2007.

8.     Жорданиа К.И. Некоторые аспекты диагностики и лечения рака яичников. Русскиймедицинский журнал. 2003; 5: 7-8.

9.     Озолиня Л.А. и др. Цитостатики при ракеяичников и решение проблемы безопасности их применения для медицинского персонала. Русский врач. 2004; 3: 5-6.

10.   Bourne Т.Н., Reynolds K., Campbell S.Ovarian cancer screening. Curr. Opin. Radiol.1991; 3 (2): 216-224.

11.   Урманчеева А. Ф., Кутушева Г. Ф. Диагностика и лечение опухолей яичника. Монография. М. 2003.

12.   Edelman R. et al. Clinical MagneticResonance Imaging. Philadelphia: W.B.Saunders. 2006; 3: 2974-3002.

13.   Урманчеева А.Ф., Мешкова И.Е. Вопросыэпидемиологии и диагностики рака яичников. Практическая онкология. 2000; 4: 8-20.

14.   Reznek Rodney et al. Cancer of the Ovary.Cambridge university press. 2007-2177.

15.   BerekJ.S., Hacker N.F. Ovarian and fallopiantubes. In: C.M. Haskell (ed.). CancerTreatment (4th ed.). Philadelphia: W. B.Saunders. 1995.

16.   Hamm B., Ferstner R. MRI and CT of thefemele pelvis. Germany: Springer. 2007; 50-75.

17.   Sohaib S. A., Sahdev A., Van Trappen P. O. etal. Characterization of adnexal mass lesionson MR imaging. Am. J. Roentgenol. 2003; 180:1297-1304.

18.   Kurjak A. et al. Transvaginal ultrasound colorflow and Doppler waveform of the post-menopausal adnexal mass. Obstet. Gynecol.1992;80: 917-921.

19.   Brown D.L., Frates M.C., Laing F.C. et al. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? Radiology. 1994; 190: 330-336.

20.   Демидов В.И. и др. Пограничные опухоли,рак и редкие опухоли яичников. М. 2005;5-106.

21.   Marret H., Sauget S., Giraudeau B. et al.Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J. Ultrasound. Med. 2004; 23:1629-1639.

22.   Hillaby K. et al. The value of detection ofnormal ovarian tissue (the «ovarian crescentsign») in the differential diagnosis of adnexalmasses. Ultrasound. Obstet. Gynecol. 2004; 23:63-67.

23.   Guerriero S., Alcazar J.L., Ajossa S. et al.Comparison of conventional colour Dopplerimaging and power Doppler imaging for thediagnosis of ovarian cancer: results of aEuropean study. Gynecol. Oncol. 2001; 83:299-304.

24.   Low R.N., Carter W.D., Saleh E et al. Ovariancancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy and CT. Radiology.1995; 195: 391-400.

25.   Williams S.D. Germ cell tumors. In: R.F. Ozols(ed.), Ovarian Cancer. Philadelphia: W.B.Saunders. 1992; 967-974.

26.   Thurnher S., Hodler J., Baer S. et al.Gadolinium-DOTA enhanced MR imaging ofadnexal tumors. J. Comput. Assist. Tomogr. 1990;14: 939-949.

27.   Rohren E.M., Turkington T.G., Coleman R.E.Clinical applications of PET in oncology.Radiology. 2004; 231: 305-332.

28.   Therasse S. G. et al. New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research andTreatment of Cancer, National CancerInstitute of the United States, NationalCancer Institute of Canada. J. Natl. Cancer.Inst. 2000; 92: 205-216.

29.   Avril А., Sassen S., Schmalfeldt B. et al.Prediction of response to neoadjuvantchemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.J. Clin. Oncol. 2005; 23: 7445-7453.

30.   Willemse P.H. et al. Interaperitoneal humanrecombinant interferon alfa-2b in minimal residual ovarian cancer. Eur. J. Cancer. 1990; 26: 353-358.

31.   Yamashita Y., Torashima M., Hatanaka Y. et al.Adnexal masses: accuracy of characterizationwith transvaginal US and precontrast andpostcontrast MR imaging. Radiology. 1995;194: 557-565.

32.   Forstner R., Hricak H., Powell C.B. et al.Ovarian cancer recurrence: value of MRimaging. Radiology. 1995; 196: 715-720.

33.   Komatsu T. et al. Adnexal masses: transvaginalUS and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology. 1996; 198: 109-115.

34.   Low R.N., Saleh F., Song S.Y. et al. Treatedovarian cancer: comparison of MR imagingwith serum CA-125 level and physical examination - a longitudinal study. Radiology. 1999;211:519-528.

35.   Prayer L., Kainz C., Kramer J. et al. CT andMR accuracy in the detection of tumorrecurrence in patients treated for ovariancancer. J. Comput. Assist. Tomogr. 1993; 17:626-632. (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы